MLKL and breast carcinoma: Furthermore, Liu et al. [142] reported that lack of RIPK1, RIPK3 and MLKL expression in breast cancer cells significantly lessens their proliferation and migration capacity in vitro and attenuates their ability to produce tumors in vivo.